key: cord-0983613-6qemm676
authors: Rolta, Rajan; Yadav, Rohitash; Salaria, Deeksha; Trivedi, Shubham; Imran, Mohammad; Sourirajan, Anuradha; Baumler, David J.; Dev, Kamal
title: In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly
date: 2020-08-27
journal: Journal of biomolecular structure & dynamics
DOI: 10.1080/07391102.2020.1804457
sha: 922346f394134b7f5c2c0cf1fe742a19f37bddb2
doc_id: 983613
cord_uid: 6qemm676

Currently, there is no specific treatment to cure COVID-19. Many medicinal plants have antiviral, antioxidant, antibacterial, antifungal, anticancer, wound healing etc. Therefore, the aim of the current study was to screen for potent inhibitors of N-terminal domain (NTD) of nucleocapsid phosphoprotein of SARS-CoV-2. The structure of NTD of RNA binding domain of nucleocapsid phosphoprotein of SARS coronavirus 2 was retrieved from the Protein Data Bank (PDB 6VYO) and the structures of 100 different phytocompounds were retrieved from Pubchem. The receptor protein and ligands were prepared using Schrodinger’s Protein Preparation Wizard. Molecular docking was done by using the Schrodinger’s maestro 12.0 software. Drug likeness and toxicity of active phytocompounds was predicted by using Swiss adme, admetSAR and protox II online servers. Molecular dynamic simulation of the best three protein- ligand complexes (alizarin, aloe-emodin and anthrarufin) was performed to study the interaction stability. We have identified three potential active sites (named as A, B, C) on receptor protein for efficient binding of the phytocompounds. We found that, among 100 phytocompounds, emodin, aloe-emodin, anthrarufin, alizarine, and dantron of Rheum emodi showed good binding affinity at all the three active sites of RNA binding domain of nucleocapsid phosphoprotein of COVID-19.The binding energies of emodin, aloe-emodin, anthrarufin, alizarine, and dantron were −8.299, −8.508, −8.456, −8.441, and −8.322 Kcal mol(−1) respectively (site A), −7.714, −6.433, −6.354, −6.598, and −6.99 Kcal mol(−1) respectively (site B), and −8.299, 8.508, 8.538, 8.841, and 8.322 Kcal mol(−1) respectively (site C). All the active phytocompounds follows the drug likeness properties, non-carcinogenic, and non-toxic. Theses phytocompounds (alone or in combination) could be developed into effective therapy against COVID-19. From MD simulation data, we found that all three complexes of 6VYO with alizarin, aloe-emodin and anthrarufin were stable up to 50 ns. These phytocompounds can be tested further for in vitro or in vivo and used as a potential drug to cure SARS-CoV-2 infection. Communicated by Ramaswamy H. Sarma

During the end of year 2019, a venomous corona disease was emerged from the city of Wuhan, China (Baloch et al., 2020) . In a short span of time, corona has spread all across the globe. This newly emerged viral disease was named as coronavirus disease (COVID-19 and also known as SARS-CoV-2) and World Health Organization (WHO) declared COVID-19 as global health emergency. The COVID-19 is transmitted through person to person and by so far has affected 213 countries across the World. Like other coronaviruses, SARS-CoV-2 has large genome (positive-sense, single-stranded RNA) size of around 30 kb, subdivided into 14 open reading frames (ORFs) (Gordon et al., 2020) . The 5 0 -ORF 1a/ORF 1ab encodes for a polyprotein, which is further processed into 16 non-structural proteins (nsp1-16) by proteolytic cleavage (Gordon et al., 2020) . The 3 0 -end of the RNA genome encodes for 13 ORFs for four structural proteins, such as the matrix (M), small envelope (E), spike (S) and nucleocapsid phosphoprotein (N), and facilitate entry of SARS-CoV-2entry to human cells through human angiotensin converting enzyme 2 (ACE2) receptor (Gordon et al., 2020) . Both structural and non-structural proteins ensure virus entry into the cells and its replication inside the host cell and therefore serve as potential as drug targets. The current antiviral drugs developed to treat coronavirus (CoV) infections primarily target S protein, the 3 C-like (3CL), and papain-like (PLP) proteases (Ramajayam et al., 2011; Wrapp et al., 2020) . The mutations in the S-protein could lead to escape of viral target by the drugs (Wrapp et al., 2020) whereas antiviral proteases could act on off targets and leads to potential side effects. Therefore, it is important to identify novel antiviral targets that could inhibit assembly of the virus particles. Viral nucleocapsid protein (N) is a potential antiviral drug target, serving multiple critical functions during the viral life cycle, including packaging the viral RNA genome (Baric et al., 1988; Cong et al., 2020; McBride et al., 2014; Nelson et al., 2000) . The N-protein binds viral RNA genome and results in the formation of ribonucleoprotein (RNP) complex (Masters & Sturman, 1990; Nelson et al., 2000) . The coronavirus N protein has distinct N-terminal RNA-binding domain (NTD), a Cterminal dimerization domain (CTD), and an intrinsically disordered central Ser/Arg (SR)-rich linker (Chen et al., 2013; Lo et al., 2013) . It is been proposed that NTD is responsible for RNA binding protein and very crucial for transcription and replication of viral RNA (Grossoehme et al., 2009; Saikatendu et al., 2007) . Many critical amino acid residues have been identified for RNA binding and virus infectivity in the N-terminal domain (NTD) of coronavirus N proteins (Tan et al., 2006) . Therefore, NTD of nucleocapsid (N) protein RNA binding domains could be one of the essential drug targets to prevent assembly of virus particles (Kang et al., 2020) .

Currently, there are really no approved drugs for the specific treatment of COVID-19. The COVID-19 is spreading at a much higher rate and the speed of drug discovery is quite slow and lengthy process. In order to speed up the process of drug development against COVID-19, there is an urgent need to take parallel and multidirectional approach to counter the spread of the virus. The approach to develop a vaccine from the scratch is a time taking process and not very good option for stopping an ongoing pandemic. The alternative approach is repurposing existing drugs such as remedesivir and chloroquine against COVID-19 could be a big step forward to curtail the growing threat (Sanders et al., 2020) , but not yet approved by US-FDA for the treatment of COVID-19. This approach to new drug discovery against COVID-19 could be further boosted by in silico (hypothesisbased drug designing) approach and repurposing more existing FDA approved drugs (Ganjhu et al., 2015; Gupta, 2020) . Moreover, phytocompounds of many medicinal plants have been traditionally used to cure many viral and respiratory diseases (Ben-Shabat et al., 2020; Ganjhu et al., 2015) . Schwarz et al. (2011) , specifically reported that emodin (major phytocompound of Rheum emodi) act as inhibitor of 3a ion channel of corona virus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC4. Ho et al. (2007) identified emodin as an effective blocker of interaction of the SARS-CoV S protein with the ACE2 and the infection by S protein-pseudo-typed retrovirus. It was shown that the major phytocompounds of Thymus serpyllum, Berberis aristate, Moringa oleifera, Zanthoxylum armatum, Piper nigrum, Myristica fragrans, Thalictrum foliolosum, Cymbopogon citrates and Allium sativum are responsible for the antimicrobial, antiviral, antioxidant, anti-inflammatory, anti-HIV anti-carcinogenic properties (Aja et al., 2014; Fenwick & Hanley, 1985; Ganjhu et al., 2015; Jaric et al., 2015; Meng et al., 1993; Nai-Lan et al., 1993; Potdar et al., 2012; Sharma et al., 2020; Singh & Shikha, 2017; Takooree et al., 2019; Tsai et al., 1985; Oladeji et al., 2019; Weber et al., 1992) .

In silico screening of such phytocompounds against specific targets of COVID-19 could provide a continuous feed for in vitro testing and clinical trials. Recently, Kang et al. (2020) , solved the crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain and proposed as unique target for developing therapeutics against COVID-19. Therefore, the current study was undertaken to test in silico inhibitory potential of 100 major phytocompounds of ten different medicinal plants including major phytocompounds of R. emodi against NTD of nucleocapsid protein RNA binding protein. The phytocompounds identified through in silico studies could become a feeder line for in vitro testing and clinical trials and therefore speed up the process of drug discovery against COVID-19 Figure 1.

The structure of N-terminal domain (NTD, involved in RNA binding) of nucleocapsid phosphoproteinof SARS coronavirus 2 (N protein PDB ID: 6VYO; MMDB ID: 186265) was retrieved (http://www.rcsb.org/structure/6VYO; https://www.ncbi.nlm. nih.gov ( Figure 3A ) it based on the previous study by Yadav et al. (2020) . The reliability of RNA binding domain of nucleocapsid phosphoprotein was done using he PROCHECK server, which displays Ramachandran plot with distinctive properties of protein such as most favored region, additional allowed regions, generously allowed regions, Disallowed regions, The End residues, Proline, Glycine and total number of residues. Multiple sequence alignment of SARS-N-terminal domain (NTD) of nucleocapsid phosphoprotein (6VYO) was done to find out the conserved regions.

The three dimensional structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 (PDB ID: 6VYO) (global quality) was prepared using Schrodinger's Protein Preparation Wizard, by rectifying bond orders, addition of hydrogen bonds, making zero-order bonds to metal atoms, make disulphide bonds, making selenomethionine to methionine conversion, fill in lost side chains prime, erase waters from het groups, and generate het states using EpikPh 7 to þ-2 (Georgiev et al., 2005) . Protein hydrogen bonds were optimized to remodel by the overlying hydrogen's and minimized using OPLS3e force field (Lanka et al., 2019) .

Identification of the potential ligand binding sites or active site residues involved in interaction is a foremost step in docking to discover novel chemical substances (Kalyaanamoorthy & Chen, 2011) . The active site residues provide a pocket containing a variety of hydrogen donors, acceptors, hydrophilic regions and hydrophobic regions (Lionta et al., 2014) . The binding cavity in NTD of nucleocapsid protein was identified using computational tools. Grid was generated using Glide module in Maestro 12.0 Schrodinger suite. The atoms of protein were settledinside using the default parameters of the radii of Vander Waal's scaling factor of 1 Å with partial charge cut-off of 0.25 Å using OPLS3e force field. Grid of the protein was generated by Yadav et al. (2020) .

Hundred major phytocompounds of ten medicinal plants (Rheum emodi, Thymus serpyllum, Cymbopogon citrates, Moringa oleifera, Thalictrum foliolosum, Berberis aristata, Piper nigrum,Allium sativum, Myristica fragrans and Zanthoxylum armatum) were utilized for virtual screening and molecular docking study against NTD of nucleocapsid (N-protein) of COVID-19 target proteins. All the hundred phytocompounds were retrieved from the PubChem Database (https://pubchem.ncbi.nlm.nih.gov/). Ligands were prepared by using the ligand preparation module of molecular modeling package with suitable parameters like optimization, ring conformation, 2 D to 3 D conversion, and determination of protomers, tautomers and ionization states at pH 7.0; along with partial atomic charges using OPLS3e force field with root mean square deviation (RMSD) value of 0.11 Å.

Molecular docking study of selected 100 phytocompounds of 10 medicinal plants for High throughput virtual screening was performed against the NTD of nucleocapsid N-protein (PDB ID: 6YVO). HTVS with flexible docking was performed on Schrodinger's maestro 12.0 between Ligands and active sites of target protein (6YVO). All the hundred ligands were filtered out by Standard Precision docking (SP) using liganddocking process. Among hundred Ligands, the best configuration with highest docking score of virtual screening were sorted by Extra Precision (XP) with Flexible docking.

2.3.1. Binding free energies calculation using prime MM/ GBSA approach

The binding free energies of ligand and receptor complex were analyzed by prime MM/GBSA (Molecular Mechanics Generalized Born Surface Area) module of Schrodinger suite with the OPLS3e force field. The prime MM GBSA À1 approach is based on the docking complex and is used to calculate DGbind of each ligand using the below mentioned equationand as described earlier (Ramatenki et al., 2015; Tripathi et al., 2013) . Where, DEMM is the difference in the minimized energiesbetween the 6VYO-ligand complex and the sum of the energies of the unliganded6VYO and inhibitor. DGSolv isthe difference in the GBSA solvation energy of 6VYO inhibitor complex and sum of the solvation energies for the free 6VYO receptor and inhibitor complex and DGSA is the difference in surface area energies for the complex and sum of the surface area energies for the unliganded 6VYO receptor and inhibitor. MM GBSA À1 approach is used as a rescoring function to prioritize the lead inhibitors. The binding free energies obtained from MM GBSA 1 calculations were considered along with docking score to optimize the identified drug molecules.

Absorption, distribution, metabolism, excretion, and toxicity (ADMET) screening was done to determine the absorption, toxicity, and drug-likeness properties of ligands.The 3 D structures of phytocompounds (aloe-emodin, anthrarufin, alizarine, dantron and emodin) were saved in .smiles format and drug were uploaded on SWISSADME (Molecular Modeling Group of the SIB (Swiss Institute of Bioinformatics), Lausanne, Switzerland), admetSAR (Laboratory of Molecular Modeling and Design, Shanghai, China), and PROTOX webservers (Charite University of Medicine, Institute for Physiology, Structural Bioinformatics Group, Berlin, Germany) for ADMET screening. SwissADME is a web tool used for the prediction of ADME and pharmacokinetic properties of a molecule. The predicted result consists of lipophilicity, water solubility, physicochemical properties, pharmacokinetics, drug-likeness, medicinal chemistry, and Brain or Intestinal Estimated permeation method (blood-brain barrier and PGP ± prediction). admetSAR provides ADMET profiles for query molecules and can predict about fifty ADMET properties. Toxicity classes are as follows: (i) Category I contains compounds with LD50 values 50 mg kg À1 , (ii) Category II contains compounds with LD50 values > 50 mg kg À1 but 500 mg kg À1 but 5000 mg kg À1 . PROTOX is a Rodent oral toxicity server predicting LD 50 value and toxicity class of query molecule. The toxicity classes are as follows: (Class 1: fatal if swallowed (LD50 5), Class 2: fatal if swallowed (55000) (Banerjee et al., 2018) .

Molecular dynamic simulation was performed to analyze the stability of ligand-protein interactions with respect to the physical transition of the structural aspect of macromolecules to the functional relevance of the complex. In brief, MD simulation demonstrates strength, pattern, dynamic conformational changes and intermolecular properties of the interactions. Among all the complexes, best three complexes with binding site A were selected for MD simulation up 50 ns by using AMBER 18 software. The root means square deviation (RMSD), root mean square fluctuation (RMSF), intermolecular hydrogen bonds interactions, binding free energy and radius of gyration (RoG) were evaluated for the elucidation of conformational, structural and compactness of the protein-ligand complexes (Nandekar et al., 2013) . Molecular receptor topology was created by leap module of software.

Subsequently, following established protocol such as neutralization and submerging complex into the water molecule rectangular box (TIP3P) where the protein atoms were 10 Å away from the nearest edge of the box. The minimization of the solvent system was achieved by freezing the protein and removing the bad contact with restraint on the heavy atoms, first through 2500 steepest descent method and then conjugation gradient for 2000 further steps. The system was gradually heated from 0 to 300 K temperature at 1 atm pressure (NPT conditions). It was achieved for 50 ps followed by 50ps of density equilibrium and 1 ns of constant equilibrium to exchange the potential and kinetic energies. Afterward, the temperature was kept constant by using the Berendsen algorithm. The MDS was run for 50 ns to evaluate the stability of the docked ligand-receptor complexes preceded by the system equilibration for 500ps on the canonical NPT ensemble. The covalently bound hydrogen atoms were constrained by the SHAKE algorithm with 2 fs time and temperature control by Langevin dynamics. Finally, the recording was made for every 5ps using the particle-mesh Ewald summation method for treating electrostatic interaction. The RMSD, RMSF and RoG values were recorded for 50 ns.

The scheme for the current study has been summarized in Figure 2 . The secondary structure of NTD (amino acid Ala 50 to Ala 173), the RNA binding domain of nucleocapsid phosphoprotein of SARS coronavirus 2 (6VYO) is shown in Figure 3A and secondary structure topology is shown in Figure 3B . The PROCHECR server presents Ramachandran plot displaying allowed and disallowed regions with regard to back bone dihedrals of protein residues. More than 90% score of the most favored regions ensures that model has good quality. RNA binding domain of nucleocapsid phosphoprotein of SARS coronavirus 2 (6VYO) protein showed 92.5% of amino acid residues in most allowed regions (Table 1 and Figure 3C ). Multiple sequence alignment of SARS-N-terminal domain (NTD) of nucleocapsid phosphoprotein (6VYO) was done by blast to find out the conserved region. The domain hits showed similarity with Coronavirus nucleocapsid protein with E-value of 3.14e-70 and with N-terminal domain of nucleocapsid (N) protein of coronavirus; The coronavirus nucleocapsid (N) with E-value of 1.23e-54 ( Figure 4A and B). The phylogenetic tree of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 is shown in supplementary Figure S1A and Multiple sequence alignment of nucleocapsid phosphoprotein from SARS coronavirus 2 in supplementary Figure S1B . The three dimensional homo-tetrameric structure of RNA binding domain of nucleocapsid phosphoprotein of SARS coronavirus 2 (PDB ID: 6VYO) was retrieved from RCSB PDB (http://www.rscb.org/pdb) in .sdf format. The protein structure was prepared by correcting bond orders, addition of hydrogen bonds, creating zero-order bonds to metal atoms, creating disulphide bonds, creating selenomethionine to methionine conversion, fill in the missing side chains prime, deleting waters from het groups, and generate het states using EpikPh 7 to þ-2 by using Schrodinger's Protein Preparation Wizard ( Figure 5A -D).

To predict the active site of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 (PDB ID: 6VYO), protein grid was generated by using glid module in maestro 12.0 schrodinger suit. In RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 (PDB ID: 6VYO) protein, we found three different active sites, namely A, B and C with D score 1.039, 0.99 and 1.045 respectively. Active site of target protein is based on previous study Yadav et al. (2020) . The dimensions of the grid box and receptor setup were

ively with a grid space of 1 Å for all the three binding sites. Active site A was predicted between chain A and B. The chain A contributes 26 amino acid and chain B contributes 21 amino acids. The Active site B was predicted between chain A (25 amino acids) and chain B (26 amino acids). Active site C was predicted between chain C and D with 15and 21 amino acids respectively (Table 2 and Figure 5 A-D). This is important to mention that Thr 76, Ser 78, Ser 105, Thr 166 which are potential phosphorylation sites are involved in formation of active sites A, B and C (Table 2; Yadav et al., 2020) .

Hundred major phytocompounds of ten selected medicinal plants (Rheum emodi, Thymus serpyllum, Cymbopogon citrates, Moringa oleifera, Thalictrum foliolosum, Berberis aristata, Piper nigrum, Allium sativum, Myristica fragrans and Zanthoxylum armatum) were used for the docking studies. The 3-dimensional structures of all the phytocompounds were obtained from pubchem (www.pubchem.com) in .sdf format. The .sdf file of phytocompounds was converted into PDB format by using the tool Open Babel. Table 3 summarizes the names of the medicinal plants, pharmacological properties and major phytocompounds. Phytocompounds are numbered as 1-100. Figure 6 showed five phytocompounds of R. emodi, which showed very efficient binding with NTD of nucleocapsid phosphoprotein of SARS coronavirus 2. Figure 6 . The remaining 95 phytocompounds did not show efficient binding (data not shown) and hence were not pursued further.

Active site A was predicted between chain A and Chain B with D score 1.039. Among all the selected phytocompounds, only aloe-emodin, anthrarufin, alizarine, dantron and emodin showed the best interaction with docking score À8.508, À8.456, À8.441, À8.322 and À8.299 Kcal mol À1 respectively. Prime MM GBSA À1 (Kcal mol À1 ), hydrogen bonding and interactive amino acids are shown in Table 4 , Figures 7 and 8 . Apart from hydrophobic interactions, Hbonds were also detected. Ser 78 of chain B, which has been predicted as phosphorylation site showed interaction with all the five phytocompounds.

Active site B was predicted between chain A and chain With D score 0.99. Among all the selected phytocompounds, only emodin, dantron, alizarine, aloe-emodin and anthrarufin Each amino acid residue is numbered followed by three letter code. Amino acid residues in boldface letters are the phosphorylation sites on Serine and Threonine were predicted by Davidson et al. (2020) . Nonstandard amino acids are CL, GOL, HOH, MES, ZN. Table 3 . List of hundred major phytocompounds (numbered 1-100) of 10 medicinal plants with pharmacological properties.

Major phytocompounds Selected for the current study

Rheum emodi Treatment of Severe Acute Respiratory Syndrome (SARS) (Ho et al., 2007; Schwarz et al., 2011) . Antioxidant, antibacterial antifungal and Bioenhancer of antibiotics (Dev et al., 2017; Rolta et al., 2018a; 2020) .

(1) Alizarin, (2) Aloe-emodin, (3) Anthraquinone, (4) Anthrarufin, (5) Anthrone, (6) Chryophanol, (7) Clicoemodin, (8) Dantron, (9) Emodin, (10) Gallic acid, 

Cymbopogon citrates Anti-obesity, anti-bacterial, anti-fungal, antinociceptive, anti-oxidants anti-diarrheal, and anti-inflammatory (Singh & Shikha, 2017) . Allium sativum Anti-influenza A and B (Fenwick & Hanley, 1985) , antiviral (Meng et al., 1993; Nai-Lan et al., 1993; Tsai et al., 1985) (79) Vinyllithium, (80) Alliin, (81) Allicin, (82) (Z)-Ajoene, 

Active site C was predicted between chain A and chain d with D score 1.045. Among all the selected phytocompounds, anthrarufin, aloe-emodin, alizarine, dantron and emodin showed the best interaction with docking score À8.538, À8.508, À8.841, À8.322 and À8.299 Kcal mol À1 respectively. Prime MM GBSA À1 (Kcal mol À1 ), hydrogen Each amino acid residue is numbered followed by three letter code. Amino acid residues in boldface letters are the phosphorylation sites on Serine and Threonine were predicted by Davidson et al. (2020) .

bonding and interactive amino acid is shown in Table 6 , Figures 11 and 12 . Hydrophobic interactions and H-bonds were detected all the phytocompounds. Ser 78 of chain D, the potential phosphorylation residue was also involved in hydrophobic interaction.

The ADME properties predicted by SwissADME of selected phytocompounds are summarized in Table 7 . Consensus Log Po/w value of ˂ 5 indicates good aqueous solubility, which means that an adequate amount of drug can reach the target and can be maintained inside the body through oral administration. All the five phytocompounds have consensus Log Po/w value of <5 (Table 7) . TPSA indicates a compound ability to permeate into cells. A TPSA value of <140 Å2 is required for good permeation of compound into the cell membrane and value <90 Å2 is required to permeate through blood-brain barrier. All the selected phytocompounds have TPSA value <90 Å2, indicating good permeability of selected phytocompounds through blood-brain barrier.

Lipinski's rule of five helps to determine drug-likeness of the Each amino acid residue is numbered followed by three letter code. Amino acid residues in boldface letters are the phosphorylation sites on Serine and Threonine predicted by Davidson et al. (2020) . Each amino acid residue is numbered followed by three letter code. Amino acid residues in boldface letters are the phosphorylation sites on Serine and Threonine predicted by Davidson et al. (2020). phytocompounds; an orally active drug should not violate the rule. Both ligands showed 0 violations for Lipinski's rule of five. Toxicity predicted by PROTOX-II and admetSAR is summarized in Table 8 . Data in Table shows that all the selected phytocompounds are non-carcinogenic and non-cytotoxic in nature and are safe to administer. However, LD 50 value of emodin and artemisinin calculated from Protox II was higher than that of all other phytocompounds and chloroquine, indicating that these natural phytocompounds are safer than that of chemically synthesized chloroquine.

Among all the 100 phytocompounds, Alizarine, Aloe-emodin and Anthrarufin showed the good binding affinity with binding site NTD of nucleocapsid protein RNA binding protein of covid-19 (6VYO) and these phytocompounds follows the all parameters (RMSD, RMSF, Intermolecular hydrogen bonding, RoG and Binding free energy through MDS) for molecular dynamic simulation study.

RMSD analysis showed structural stability of protein-ligand complex with in particular time period. Protein-ligand complex behavior upto 50 ns by MDS. The RMSD values of the 6VYO with Alizarine is gradually stabilized at 3 Å and 30 ns and values are same for 50 ns. Similarly, in case of aloe-emodin RMSD value is stabilized at 4 Å and 35 ns and values are same for 50 ns. In case of Anthrarufin RMSD value is stabilized at 3.5 À 4 Å and 45 ns and values are same for 50 ns ( Figure 13A ). 

The RMSF determines the deviation of the particle from the original position of macromolecules of three dimensional structure of protein. It describes the conformational flexibility of the protein structure. We found the low fluctuation in loop of Alizarine and 6VYO complex; aloe-emodin and 6vyo complex and high fluctuation anthrarufin and 6vyo complex ( Figure 13B ).

It measures the binding affinity of ligand. Therefore more no. of hydrogen bonds between the protein and Ligands showed strong binding affinity. In this study we found maximum 27 hydrogen bond at the end of 50 ns simulation 23 hydrogen bonds in Alizarine and 22 in aloe-emodin and 24 in Anthrarufin ( Figure 14A ).

It describes the folding competence of the protein-ligand complexes. Through RoG analysis we confirm the conformational changes in the three-dimensional structure of protein after interaction of ligand. The high RoG value showed the loose packing and folding behavior of the protein ligand complex. All the complexes showed the high value at approximately 27.2 Å throughout 50 ns ( Figure 14B ).

Molecular docking studies explored the interaction of 100 major phytocompounds of ten selected medicinal plants (Rheum emodi, Thymus serpyllum, Cymbopogon citrates, Moringa oleifera, Thalictrum foliolosum, Berberis aristata, Piper nigrum, Allium sativum, Myristica fragrans and Zanthoxylum armatum) for interaction with RNA binding domain (NTD) of nucleocapsid phosphoprotein of SARS coronavirus 2.

The molecular docking study showed that out to 100 different phytocompounds,five phytocompounds such as emodin, anthrarufin, alizarine, aloe-emodin and dantron of Rheum emodishowed efficientbinding affinity and pharmacokinetic properties with NTD of RNA binding domain of nucleocapsid phosphoprotein of SARS coronavirus 2. It is very interesting to note that all the all the five phytocompounds (emodin, aloe-emodin, anthrarufin, alizarine, and dantron) of R. emodi bind at three different active sites. Thebinding energies of emodin, aloe-emodin, anthrarufin, alizarine, and dantron was À8.299, À8.508, À8.456, À8.441, and À8.322 Kcal mol À1 respectively (site A), À7.714, À6.433, À6.354, À6.598, and À6.99 Kcal mol À1 respectively (site B), and À8. 299, 8.508, 8.538, 8.841, and 8.322 Kcal mol À1 respectively (site C). Similar to our study, Kumar et al reported the binding affinities of Nelfinavir, Rhein, Withanolide D, Withaferin A, Enoxacin, and Aloe-emodin as À8.4, À8.1, À7.8, À7.7, À7.4, and À7.4 Kcal mol À1 respectively against main protease (6LU7) of COVID 19. Latha and Pandit (Latha & Pandit, 2020) reported the binding affinity of phytocompounds derived from Silybum marianum (Silybin), Withania somnifera (Withaferin A), Tinospora cordifolia (Cordioside) and Aloe barbadensis (Catechin and Quercetin) with SARS-CoV-2 target. The binding energies of phytocompounds was more than the widely used hydroxychloroquine and other repurposed drugs used for treatment of COVID-19 infection. Tatar and Turhan (2020) reported the Table 7 . ADME properties of selected phytocompounds predicted by SwissADME. binding affinity of nafamostat, rapamycin, saracatinib, Imatinib and Camostat with binding energy À10.24, À9.28, À9.66, À9.23 and 9.07 respectively with N-Terminal Domain of SARS-CoV-2 Nucleocapsid. Ubani et al. (2020) reported best binding affinity of scopodulcic acid and 249 Dammarenolic acid with the Spike glycoprotein (6VSB) and the Mpro 250 (6FLU7) respectively. The in-silico studies were supported by the fact that Schwarz et al. (2011) reported emodin as inhibitor of 3a ion channel of corona virus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43. In another study, Ho et al. (2007) identified emodin as an effective to block the interaction of the SARS-CoV S protein with the ACE2 and the infection by S protein-pseudo-typed retrovirus. Similar to our study, Ahmed and Shohael (Ahmed & Shohael, 2019) , reported that the chrysophanol, aloe-emodin, rhein and emodin fulfill all the criteria of Lipinski's rule of five and ADME/T. Nucleocapsid N protein of SARS coronavirus 2 has been predicted to contain many phosphorylation sites at Serine, Threonine and Tyrosine residues (Davidson et al., 2020) . In our study, we found that some of the potential Serine and Threonine residues contribute for the formation of active site A, B and C. Serine at position 78, 79 and 105 also showed interaction with all the five phytocompounds of R. emodi. Involvement of potential phosphorylation residues in interaction with phytocompounds could further ensure that NTD of Nucleocapsid N protein of SARS coronavirus 2 render inactive and prevents the assembly of the virus and hence stop the infection.

Hundred phytocompounds of ten medicinal plants were screened on the bases of binding energy against NTD of Nucleocapsid protein of COVID-19 target. Among all the 100 phytocompounds, emodin, Anthrarufin, Alizarine, Aloe-emodin, and Dantron showed the good binding affinity at three different active sites of N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein and potentially prevent the assembly of virus particles and stop the infection, ADMET prediction revealed that emodin, Anthrarufin, Alizarine, Aloe-emodin, and Dantron are potential drugs for COVID-19 treatment. Molecular dynamic simulation of the three protein-ligand complexes (alizarin, aloe-emodin and anthrarufin) showed stable interaction for 50 ns.

Authors are thankful to the Department of Pharmacology, AIIMS, Rishikesh, Dr. Prajwal Nandekar, Dr. Vinod and Schrodinger team

Dheeraj Kumar Chaurasia from Supercomputing facility for Bioinformatics and Computational Biology

In silico studies of four anthraquinones of Senna alataL. as potential antifungal compounds

Chemical constituents of Moringa oleifera leaves and seeds from Abakaliki

Potential for global spread of a novel coronavirus from China

ProTox-II: a webserver for the prediction of toxicity of chemicals

Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription

Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies

Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein

Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle

In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach

Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced inframe deletion in the spike glycoprotein that removes the furin-like cleavage site

Herbal Pharmaceutical Excipient for Enhancing Antifungal and Antibacterial Properties of Existing Drugs. Indian Patent Filing Number

Allium species poisoning. The Veterinary Record

Herbal plants and plant preparations as remedial approach for viral diseases

Smoothing-Strichartz estimates for the Schrodinger equation with small magnetic potential

A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing

Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes

Elucidating the Phytochemical and Pharmacological Potential of Myristicafragrans (Nutmeg)

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

Review of ethnobotanical, phytochemical, and pharmacological study of Thymus serpyllum L. Evid. Based Complement. Evidence-Based Complementary and Alternative Medicine : Ecam

Structure-based drug design to augment hit discovery

Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2

Structure-based identification of potential novel inhibitors targeting FAM3B (PANDER) causing type 2 diabetes mellitus through virtual screening

In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection

Structurebased virtual screening for drug discovery: Principles, applications and recent advances

Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein

Background paper. Functions of the coronavirus nucleocapsid protein

The coronavirus nucleocapsid is a multifunctional protein

Anti-HCMV effect of garlic components

Demonstration of antiviral activity of garlic extract against human cytomegalovirus in vitro

Chem-bioinformatics and in vitro approaches for candidate optimization: A case study of NSC745689 as a promising antitumor agent

High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA

Phytochemistry and pharmacological activities of Cymbopogon citratus: A review

Antimicrobial action of the leaf extract of Moringa oleifera Lam

Phyto-chemical and pharmacological applications of Berberis aristata

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery

Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer

Bioassay guided fractionation of rhizome extract of Rheum emodi wall as bio-availability enhancer of antibiotics against bacterial and fungal pathogens

Methanolic Extracts of the Rhizome of R. emodi Act as Bioenhancer of Antibiotics against Bacteria and Fungi and Antioxidant Potential

Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review

Emodin inhibits current through SARS-associated coronavirus 3a protein

Thalictrum foliolosum: A lesser unexplored medicinal herb from the Himalayan region as a source of valuable benzyl isoquinoline alkaloids

Zanthoxylumarmatum DC: Past, present and future prospective

A systematic review on black pepper (Piper nigrum L.): From folk uses to pharmacological applications

Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells

Investigation of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with Antiviral Compounds Based on Molecular Modeling Approach

Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors

Antiviral properties of garlic: In vitro effects on influenza B, herpes simplex and coxsackie viruses

Molecular Docking Analysis of Some Phytochemicals on Two SARS-CoV-2 Targets. bioRxiv

In vitro virucidal effects of Allium sativum (garlic) extract and compounds

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2

The authors acknowledge Shoolini University, Solan (India) for providing infrastructure support to conduct the research work. Authors also acknowledge the support provided by Yeast Biology Laboratory, School 

The authors declare that they have no conflicts of interest.